Inching closer to precision treatment for rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1038/s41591-022-01857-5
Published Online: 2022-06-09
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Donlin, Laura T. http://orcid.org/0000-0002-1428-090X
Text and Data Mining valid from 2022-06-01
Version of Record valid from 2022-06-01
Article History
First Online: 9 June 2022
Competing interests
: L.T.D. is a member of the NIH-industry sponsored Accelerating Medicines Partnership consortium.